MSA
EW icon

MUFG Securities Americas’s Edwards Lifesciences EW Stock Holding History

MUFG Securities Americas’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.29M Buy
16,057
+424
+3% +$35K 0.08% 220
2025
Q4 		$1.33M Sell
15,633
-199
-1% -$16.3K 0.08% 209
2025
Q3 		$1.23M Buy
15,832
+2,832
+22% +$221K 0.08% 220
2025
Q2 		$1.02M Buy
13,000
+2,560
+25% +$191K 0.09% 207
2025
Q1 		$757K Buy
10,440
+1,734
+20% +$124K 0.09% 215
2024
Q4 		$645K Buy
+8,706
New +$609K 0.08% 214

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MUFG Securities Americas's EW Position: Q1 2026 in Review

MUFG Securities Americas increased its Edwards Lifesciences (EW) stake by 2.7% in Q1 2026, buying an estimated $35K and bringing the position to 16,057 shares worth $1.29M. The position accounts for 0.08% of the portfolio, ranked #220.

MUFG Securities Americas first reported a position in EW in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.33M in Q4 2025. 1,285 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • MUFG Securities Americas held 16,057 shares of Edwards Lifesciences worth $1.29M as of Q1 2026.
  • MUFG Securities Americas bought 424 Edwards Lifesciences shares in Q1 2026, an estimated $35K.
  • Edwards Lifesciences made up 0.08% of MUFG Securities Americas's portfolio in Q1 2026, its #220 holding.
  • MUFG Securities Americas first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 6 quarters since.
  • MUFG Securities Americas's Edwards Lifesciences position peaked at $1.33M in Q4 2025.
  • 1,285 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on MUFG Securities Americas's 13F filing for Q1 2026, filed 11 May 2026.